Our study is based on trials retrieved from an extensive literature search to identify all relevant eligible trials comparing combination of ARB plus ACE inhibitor therapy to ACE inhibitor therapy alone in patients with congestive heart failure. This evidence concerns the gene ACE and congestive heart failure.